Correction to: Oncogene (2015) 00, XXXX; doi:10.1038/onc.2015.242; published online 14 September 2015
Since the online publication of this article the authors noticed an error in one of the author affiliations. Affiliation 1 should read as follows:
INSERM UMR 866, «Equipe labellisée» Ligue National contre le Cancer and Laboratoire d’Excellence LipSTIC, Dijon, France
The authors apologise for any inconvenience caused by this error.
This error has now been rectified, and the corrected article appears in this issue. The html and online pdf versions have also been rectified, and now carry the corrected paper.
Additional information
The online version of the original article can be found at 10.1038/onc.2015.242
Rights and permissions
About this article
Cite this article
Joly, AL., Deepti, A., Seignez, A. et al. Erratum: The HSP90 inhibitor, 17AAG, protects the intestinal stem cell niche and inhibits graft versus host disease development. Oncogene 35, 2948 (2016). https://doi.org/10.1038/onc.2016.63
Published:
Issue Date:
DOI: https://doi.org/10.1038/onc.2016.63
This article is cited by
-
Selecting the first chemical molecule inhibitor of HSP110 for colorectal cancer therapy
Cell Death & Differentiation (2020)
